← Back to Search

DNA Screening Test

Individuals eligible for CRC Screening for Colorectal Cancer

N/A
Waitlist Available
Led By Thomas Imperiale, MD
Research Sponsored by Exact Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Do you have an upcoming colonoscopy scheduled?
Are you over the age of 40?
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial will test a new method for detecting colorectal cancer. The aim is to see if it is more accurate than current methods.

Eligible Conditions
  • Colorectal Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Is your upcoming colonoscopy the first one you have ever had?

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: Individuals eligible for CRC ScreeningExperimental Treatment3 Interventions
Individuals who are 40 years of age and older, eligible for CRC screening, and scheduled for a screening colonoscopy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
mt-sDNA 2.0 screening test
2019
N/A
~26760
FIT test
2019
N/A
~26760
Colonoscopy
2012
Completed Phase 3
~115560

Find a Location

Who is running the clinical trial?

Exact Sciences CorporationLead Sponsor
33 Previous Clinical Trials
232,782 Total Patients Enrolled
Thomas Imperiale, MDPrincipal InvestigatorIndiana University
4 Previous Clinical Trials
39,657 Total Patients Enrolled
~4587 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top